These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 507348)

  • 1. Intravenous erythromycin in acute chest infections in critically ill patients.
    Cade JF; Pain MC
    Anaesth Intensive Care; 1979 May; 7(2):143-7. PubMed ID: 507348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous administration of erythromycin: serum, sputum and urine levels.
    Neaverson MA
    Curr Med Res Opin; 1976; 4(5):359-64. PubMed ID: 1009781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified treatment of acute lower respiratory tract infection with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
    Daniel R
    J Int Med Res; 1991; 19(5):373-83. PubMed ID: 1660824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flurithromycin ethylsuccinate in the treatment of lower respiratory tract bacterial infections.
    Bariffi F; Clini V; Ginesu F; Mangiarotti P; Romoli L; Gialdroni-Grassi G
    Infection; 1994; 22(3):226-30. PubMed ID: 7927827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Another look at erythromycin.
    Straughan JL
    S Afr Med J; 1978 Apr; 53(14):527-30. PubMed ID: 354037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravenous erythromycin lactobionate in respiratory infections.
    Di Sciacca A; Durante F; Cucchiara G; Ingrassia A; Mira G; Mannone F; Di Piazza RM; Frontini A; Barbagallo Sangiorgi G
    J Int Med Res; 1987; 15(4):245-50. PubMed ID: 3653502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory symptoms due to Branhamella catarrhalis and other Neisseria species infections--response to erythromycin therapy.
    Hamedani P; Hafiz S; Ali J; Memon R; Ali S; Ali M; Ansari M; Siddique I; Raza R
    Clin Ther; 1989; 11(5):633-9. PubMed ID: 2509070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.
    Peters DH; Friedel HA; McTavish D
    Drugs; 1992 Nov; 44(5):750-99. PubMed ID: 1280567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new look at erythromycin.
    Lacey RW
    Postgrad Med J; 1977 Apr; 53(618):195-200. PubMed ID: 323837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and amoxycillin. European Azithromycin Study Group.
    Felstead SJ; Daniel R
    J Int Med Res; 1991; 19(5):363-72. PubMed ID: 1660823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin infusions for treatment of infections in the ear, nose and throat region.
    Blenk H; Blenk B; Jahneke G; Simm K; von Lucke B; LaFranier D
    J Int Med Res; 1980; 8 Suppl 2():41-6. PubMed ID: 7429005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pharmacokinetics of 1,000 mg erythromycin lactobionate i. v. in patients with respiratory tract infections (author's transl)].
    Sietzen W
    Infection; 1982; 10 Suppl 2():S99-101. PubMed ID: 7107025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two oral forms of erythromycin in the treatment of acute respiratory tract infections. A multicentre general practice study.
    Macklin J; Barden R; Coles S
    J Int Med Res; 1989; 17(3):287-94. PubMed ID: 2670633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute bacterial infections of the upper respiratory tract.
    Nadkarni MS; Shah PA; Thakurdesai S
    Curr Med Res Opin; 1977; 4(8):544-54. PubMed ID: 326492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Multicenter study of the clinical efficacy and tolerance of roxithromycin compared to erythromycin ethylsuccinate in lower respiratory tract infections].
    Bertrand A; Jonquet O; Sauvaget J
    Pathol Biol (Paris); 1988 May; 36(5):544-7. PubMed ID: 3043354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of flurythromycin ethylsuccinate in infections of lower airways due to sensitive germs: multicenter comparative study with clarithromycin.
    Vagliasindi M
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):245-9. PubMed ID: 9208340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentration/time curve of erythromycin after a 12-hour intravenous infusion of erythromycin lactobionate in man.
    Parsons RL; David J; Paddock GM; Stamp ST
    Postgrad Med J; 1978 Feb; 54(628):68-71. PubMed ID: 345253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of a new antibacterial agent, xibornol, in the treatment of bacterial infections of the upper respiratory tract in childhood. Comparison with erythromycin].
    Capristo AF; Maiello N; Coppola T; Decimo F; Miraglia del Giudice M; Antignani RG
    Minerva Pediatr; 1986 Jun; 38(11-12):503-10. PubMed ID: 3526110
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral therapy with flurithromycin in ear, nose and throat infections.
    Galioto GB; Passali D; Catalano GB; Mevio E; Lepore AM; Romoli L
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):204-7. PubMed ID: 7620689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.